Back to REGN
Bellecapital International Ltd. → REGN
Bellecapital International Ltd. REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$21.6M
Q3 2026
Peak value
$21.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $17.8M |
| Q1 2026 | $18.9M |
| Q1 2026 | $18.8M |
| Q2 2026 | $17.2M |
| Q3 2026 | $21.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $21.6M | 28.5K | — | — |
| Q2 2026 | $17.2M | 27.6K | — | — |
| Q1 2026 | $18.8M | 24.3K | — | — |
| Q1 2026 | $18.9M | 24.4K | — | — |
| Q4 2025 | $17.8M | 23.1K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B